{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:31:26Z","timestamp":1793633486425,"version":"4.5.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.omtn.2026.103097","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T09:07:34Z","timestamp":1790413654000},"page":"103097","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rebuilding a protective allele with ADAR site-directed RNA editing"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1747-0853","authenticated-orcid":false,"given":"Michael F.","family":"Jantsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7509-414X","authenticated-orcid":false,"given":"\u00c2ngela S.","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2026.103097_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/15476286.2021.1983288","article-title":"Site-directed RNA editing: recent advances and open challenges","volume":"18","author":"Khosravi","year":"2021","journal-title":"RNA Biol."},{"key":"10.1016\/j.omtn.2026.103097_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmr.2025.100086","article-title":"The evolution of lipid-lowering drugs in the management of cardiovascular disease risk: From the first cardiovascular disease risk\u2013reducing therapies to the novel challenging strategies","volume":"77","author":"Henry","year":"2025","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.omtn.2026.103097_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2026.103001","article-title":"ADAR RNA editing for cardiovascular disease: Targeting B4GALT1 to modulate lipid metabolism through reduced galactosyltransferase activity","volume":"37","author":"De Chiara","year":"2026","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2026.103097_bib4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.31083\/j.rcm2508286","article-title":"Therapeutic Gene Editing in Dyslipidemias","volume":"25","author":"Tamehri Zadeh","year":"2024","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.omtn.2026.103097_bib5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.abe0348","article-title":"Genetic and functional evidence links a missense variant in B4GALT1 to lower LDL and fibrinogen","volume":"374","author":"Montasser","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.omtn.2026.103097_bib6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1093\/cvr\/cvaa252","article-title":"Impact of protein glycosylation on lipoprotein metabolism and atherosclerosis","volume":"117","author":"Pirillo","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.omtn.2026.103097_bib7","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jpeds.2011.08.007","article-title":"B4GALT1-congenital disorders of glycosylation presents as a non-neurologic glycosylation disorder with hepatointestinal involvement","volume":"159","author":"Guillard","year":"2011","journal-title":"J. Pediatr."},{"key":"10.1016\/j.omtn.2026.103097_bib8","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/emboj\/16.8.1850","article-title":"Growth retardation and early death of beta-1,4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells","volume":"16","author":"Asano","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.omtn.2026.103097_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/21593337251415115","article-title":"Programmable RNA Editing via Adenosine Deaminase Acting on RNA Enzymes: Current Advances and Clinical Potential","volume":"36","author":"Kim","year":"2026","journal-title":"Nucleic Acid Therapeut."},{"key":"10.1016\/j.omtn.2026.103097_bib10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.3c00174","article-title":"PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective","volume":"34","author":"Tenchov","year":"2023","journal-title":"Bioconjug. Chem."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253126002684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:17:44Z","timestamp":1793632664000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253126002684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S2162253126002684"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103097","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rebuilding a protective allele with ADAR site-directed RNA editing","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2026.103097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"103097"}}